ATE360415T1 - Behandlung von dyskinesie - Google Patents
Behandlung von dyskinesieInfo
- Publication number
- ATE360415T1 ATE360415T1 AT03748249T AT03748249T ATE360415T1 AT E360415 T1 ATE360415 T1 AT E360415T1 AT 03748249 T AT03748249 T AT 03748249T AT 03748249 T AT03748249 T AT 03748249T AT E360415 T1 ATE360415 T1 AT E360415T1
- Authority
- AT
- Austria
- Prior art keywords
- dyskinesia
- treatment
- topiramate
- parkinsonism
- dopa
- Prior art date
Links
- 208000012661 Dyskinesia Diseases 0.000 title abstract 3
- KJADKKWYZYXHBB-XBWDGYHZSA-N Topiramic acid Chemical compound C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 KJADKKWYZYXHBB-XBWDGYHZSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229960004394 topiramate Drugs 0.000 abstract 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 abstract 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 abstract 1
- 208000016285 Movement disease Diseases 0.000 abstract 1
- 235000010676 Ocimum basilicum Nutrition 0.000 abstract 1
- 240000007926 Ocimum gratissimum Species 0.000 abstract 1
- 208000027089 Parkinsonian disease Diseases 0.000 abstract 1
- 206010034010 Parkinsonism Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000000609 ganglia Anatomy 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Resistance Heating (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41159702P | 2002-09-17 | 2002-09-17 | |
| GB0307824A GB0307824D0 (en) | 2003-04-04 | 2003-04-04 | Treatment of dyskinesia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE360415T1 true ATE360415T1 (de) | 2007-05-15 |
Family
ID=32031898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03748249T ATE360415T1 (de) | 2002-09-17 | 2003-09-01 | Behandlung von dyskinesie |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060069039A1 (de) |
| EP (1) | EP1539135B1 (de) |
| JP (1) | JP2006502234A (de) |
| CN (1) | CN100502856C (de) |
| AT (1) | ATE360415T1 (de) |
| AU (1) | AU2003267557B2 (de) |
| CA (1) | CA2499200A1 (de) |
| CY (1) | CY1106759T1 (de) |
| DE (1) | DE60313474T2 (de) |
| DK (1) | DK1539135T3 (de) |
| ES (1) | ES2286453T3 (de) |
| PT (1) | PT1539135E (de) |
| WO (1) | WO2004026299A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9924941D0 (en) * | 1999-10-22 | 1999-12-22 | Univ Manchester | Treatment of dyskinesia |
| GB0027020D0 (en) * | 2000-11-03 | 2000-12-20 | Univ Manchester | Treatment of movement disorders |
| US20070179161A1 (en) * | 2003-03-31 | 2007-08-02 | Vernalis (Cambridge) Limited. | Pyrazolopyrimidine compounds and their use in medicine |
| KR20120103557A (ko) * | 2009-07-31 | 2012-09-19 | 클레라 아이엔씨. | 파킨슨씨병 치료용 조성물 및 치료방법 |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| CN107660147B (zh) * | 2015-05-26 | 2021-04-30 | 抗菌技术生物技术研究与发展股份有限公司 | 用于治疗帕金森病和相关障碍的组合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU179018B (en) * | 1978-10-19 | 1982-08-28 | Gyogyszerkutato Intezet | Process for producing new 5h-2,3-benzodiazepine derivatives |
| US4452808A (en) * | 1982-12-07 | 1984-06-05 | Smithkline Beckman Corporation | 4-Aminoalkyl-2(3H)-indolones |
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| US4582916A (en) * | 1983-09-26 | 1986-04-15 | Mcneilab, Inc. | Chlorosulfate and azidosulfate esters of tetrahydro-2H-pyran-2-yl-methanol |
| GB8712073D0 (en) * | 1987-05-21 | 1987-06-24 | Smith Kline French Lab | Medicament |
| DE19604920A1 (de) * | 1996-02-01 | 1997-08-07 | Schering Ag | Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel |
| MXPA01010217A (es) * | 1999-04-08 | 2005-09-08 | Johnson & Johnson | Derivados anticonvulsivos utiles en el tratamiento de trastornos neurodegenerativos cronicos. |
| US6420369B1 (en) * | 1999-05-24 | 2002-07-16 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful in treating dementia |
| NZ548578A (en) * | 2001-02-02 | 2008-03-28 | Ortho Mcneil Pharm Inc | Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| US6649607B2 (en) * | 2001-05-18 | 2003-11-18 | Vela Pharmaceuticals, Inc. | Compositions and methods for treating or preventing convulsions or seizures |
| US6559293B1 (en) * | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
-
2003
- 2003-09-01 JP JP2004568894A patent/JP2006502234A/ja active Pending
- 2003-09-01 EP EP03748249A patent/EP1539135B1/de not_active Expired - Lifetime
- 2003-09-01 DK DK03748249T patent/DK1539135T3/da active
- 2003-09-01 ES ES03748249T patent/ES2286453T3/es not_active Expired - Lifetime
- 2003-09-01 CN CNB038221381A patent/CN100502856C/zh not_active Expired - Fee Related
- 2003-09-01 US US10/527,761 patent/US20060069039A1/en not_active Abandoned
- 2003-09-01 WO PCT/GB2003/003801 patent/WO2004026299A1/en not_active Ceased
- 2003-09-01 AT AT03748249T patent/ATE360415T1/de active
- 2003-09-01 DE DE60313474T patent/DE60313474T2/de not_active Expired - Lifetime
- 2003-09-01 PT PT03748249T patent/PT1539135E/pt unknown
- 2003-09-01 AU AU2003267557A patent/AU2003267557B2/en not_active Ceased
- 2003-09-01 CA CA002499200A patent/CA2499200A1/en not_active Abandoned
-
2007
- 2007-07-25 CY CY20071100993T patent/CY1106759T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006502234A (ja) | 2006-01-19 |
| DK1539135T3 (da) | 2007-09-17 |
| US20060069039A1 (en) | 2006-03-30 |
| EP1539135A1 (de) | 2005-06-15 |
| DE60313474D1 (de) | 2007-06-06 |
| WO2004026299A1 (en) | 2004-04-01 |
| CN1681491A (zh) | 2005-10-12 |
| AU2003267557A1 (en) | 2004-04-08 |
| CY1106759T1 (el) | 2012-05-23 |
| EP1539135B1 (de) | 2007-04-25 |
| CN100502856C (zh) | 2009-06-24 |
| DE60313474T2 (de) | 2008-01-03 |
| AU2003267557B2 (en) | 2009-02-26 |
| PT1539135E (pt) | 2007-07-12 |
| ES2286453T3 (es) | 2007-12-01 |
| CA2499200A1 (en) | 2004-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE368031T1 (de) | Neue gamma secretase inhibitoren | |
| DE502004006619D1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
| ATE464287T1 (de) | Cyclohexyl-sulphone als gamma-sekretase- inhibitoren | |
| DE60124085D1 (de) | Pde-v hemmer zur behandlung von morbus parkinson | |
| IS8058A (is) | Sýklísk súlfónamíð til að hamla gamma seytiasa | |
| CY1106679T1 (el) | Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα | |
| DE60026155D1 (de) | Einige alkylendiamin-substituierte heterocyclen | |
| ATE536349T1 (de) | In der 2-stellung durch phenyl substituierte 1h- benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
| EA200802213A1 (ru) | Способы лечения заболеваний крови | |
| CY1108738T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για την αγωγη του πονου | |
| ATE484508T1 (de) | Furylverbindungen | |
| BR0307998A (pt) | Hidroxietilaminas substituìdas | |
| PA8719401A1 (es) | Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo | |
| ATE461923T1 (de) | Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
| DK1664016T3 (da) | Terapeutiske midler, der er anvendelige til behandling af smerter | |
| ATE396970T1 (de) | 2-(1h-indolylsulfanyl)-benzylaminderivate als ssri | |
| ZA200501128B (en) | Biphasic composition induced by polydextrose | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
| DE60313474D1 (de) | Behandlung von dyskinesie | |
| ATE474571T1 (de) | Behandlung von melanoma mittels p- aminobenzoesäure (paba) | |
| EA200600992A1 (ru) | Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение | |
| EA200971003A1 (ru) | Бициклическое соединение и его фармацевтическое применение | |
| EA200500045A1 (ru) | Новые соединения, их применение и получение | |
| ATE464048T1 (de) | Behandlung von alzheimer-krankheit und verwandten zuständen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1539135 Country of ref document: EP |